跳至主要内容
临床试验/NCT06275347
NCT06275347已完成不适用

Comparative Study of the Response to Weight Loss and Metabolic Conditions Using Two Non-pharmacological Nutritional Programs

Universidad Veracruzana2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2021年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
2
主要终点
Bone mass

研究概览

简要总结

This study aimed to assess the efficacy and safety of the Zélé program, a controlled ketogenic diet, for weight loss and maintenance. It involved a randomized clinical trial with participants aged 18-60, BMI between 30-34.9 kg/m², and no severe health issues

详细描述

The study will be conducted in Mexico City under the sponsorship of Zélé® and in collaboration with the VIME Weight Loss and Wellness Center of Mexico. During the year 2021 and with follow-up for 24 months. An open call will be made through different media including social networks for the recruitment of patients who meet the inclusion criteria and must present themselves for a clinical evaluation in which pathological history, clinical status, heart rate, blood pressure, oxygenation and temperature will be recorded. Nutritional assessment, and a Complete Blood Count, a biochemical profile. Patients who meet all the inclusion criteria will be selected and will have an interview with the principal investigator in which they will sign their letter of commitment and informed consent, then they will be subjected to the randomization process with a 2:1 allocation for treatment and controls, respectively. Subsequently, they will be submitted to the two nutritional treatments and will be clinically evaluated every week and will receive nutritional, psycho emotional and physical activity counseling. At each visit, adverse effects, changes in clinical status will be recorded and the presence of ketone bodies in capillary blood will be determined. Subsequently, only clinical and nutritional follow-up will be given along with psycho-emotional support and physical activity advice every 3 months up to 12 months and every 6 months up to 24 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

Eligible patients were assigned to a one of the four VIME Weight Loss and Wellness Center for management and follow up according to their preference, a sequential number in inclusion order was given, with all the patients coded with a 4-digit number. This code was sent to the people in the food production plant where the patients were randomized in a double blinded study, with a 2:1 allocation for low-fat, normo-protein, controlled ketogenic diet (Zélé method) or low calories diet

入排标准

年龄范围
18 Years 至 61 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of either sex, between 18 and 60 years old, with a body mass index (BMI) between 30 and 34.9 kg/m2 were eligible to participate in the study. We recruited participants from Mexico City through different media including social networks (Facebook and Instagram). The selection was consecutive according to the order of response of the interested participants. All participants read and signed the Informed Consent form

排除标准

  • Pregnant or breastfeeding patients, patients with severe eating disorders, alcoholism, or drug addiction, patients with severe psychiatric disorders (e.g., schizophrenia, bipolar disorder, mayor depression), patients with hepatic alteration defined as increase of ALT, AST, GGT more than 4 folds the reference value, patients with renal impairment defined as a glomerular filtration rate below 60 ml/min. Patients with type 1 or insulin-dependent DM, or DM2 on insulin therapy, patients with obesity caused by endocrinological diseases (except type 2 DM), patients with hemopathies, cancer patients, patients with active cardiovascular or cerebrovascular disease (heart rhythm disorders, recent infarction [<6m], unstable angina, decompensated heart failure, recent vascular accident [<6m]), patients with gout, patients with known renal lithiasis or cholelithiasis, patients with electrolyte disorders, patients with orthostatic hypotension, patients with known an altered or abnormal electrocardiogram.

研究组 & 干预措施

Intervention Very low calorie ketogenic low-fat diet (VLCKLFD)

Experimental

Frank ketosis: between 650 and 730 kcal/day in 5 mealtimes. This stage in the nutritional intervention was done during the first 4 weeks.

Mixed Ketosis: in this stage, one intake of commercial preparations was replaced by proteins, which discreetly increased by 100 to 150 Kcal/day. This stage was done during the next 4 weeks.

干预措施: Low-fat normoprotein Controlled Ketogenic Diet. (Other)

Low-Calorie Diet (LCD)

Active Comparator

The usual caloric intake of a balanced LCD is between 1,200 and 1,500 kcal per day with a macronutrient distribution of 50% carbohydrates, 25% proteins and 25% fats, according to the Diogenes study

干预措施: Hypocaloric Balanced Diet (Other)

结局指标

主要结局

Bone mass

时间窗: Every week for 4 months, then every month for two years

the skeletal weight will be measured with unit kilograms (kg), from 1 to 70 kg, with a Multi-frequency Bioelectrical Impedance Equipment

Percentage of body weight made up of adipose tissue

时间窗: Every week for 4 months, then every month for two years

It will be measured with unit percentaje, minimum 9, maximum 90, with a Multi-frequency Bioelectrical Impedance Equipment

Waist circumference

时间窗: Every week for 4 months, then every month for two years

Measurement made with a tape measure directly on the skin (without clothing). It will be measured at the height of the middle of the armpit, at the point between the bottom of the last rib and the highest part of the hip. Unit centimeters (cm), minimum 30, maximum 200, Using tape measure

Hip circumference

时间窗: Every week for 4 months, then every month for two years

Circumference of the widest part above the buttocks. Unit cm, minimum 30, maximum 200. Measuring with tape measure

Muscular strenght

时间窗: Every week for 4 months, then every month for two years

Isometric muscle strenght in the dominant hand, unit kilograms (kg)/ Strength, registration form digital dynamometer

Weight

时间窗: Every week for 4 months, then every month for two years

it will be measured in unit kilograms, in a weighing machine

Evaluate the efficacy of this nutritional intervention

时间窗: Every week for 4 months, then every month for two years

The primary outcome measure was body weight operationalized as the change in an individual's mass or weight loss in kilograms.

Total body water

时间窗: Every week for 4 months, then every month for two years

Percentage of the body that corresponds to water, unit % (percentaje) and/ or kilograms (kg) from 0 to 150 with a Multi-frequency bioelectrical impedance equipment

Height

时间窗: Every week for 4 months, then every month for two years

The size will be measured in meters with a stadiometer

Volume of total body tissue corresponding to muscle

时间窗: Every week for 4 months, then every month for two years

It will be measured with unit Kilogram, minimun 10, maximum 150, with a Multi-frequency Bioelectrical Impedance Equipment

Visceral Fat

时间窗: Every week for 4 months, then every month for two years

It will be measured with unit index, from 1 to 40, with a Multi-frequency Bioelectrical Impedance Equipment

BMI Body index mass

时间窗: Every week for 4 months, then every month for two years

Body mass index is an index composed of weight/height squared in kg/m2.

次要结局

  • Hematocrit(Every 2 months for the first 6 months, then every 6 months for two years)
  • Leukocytes(Every 2 months for the first 6 months, then every 6 months for two years)
  • Glycated hemoglobin (HbA1c)(Every 2 months for the first 6 months, then every 6 months for two years)
  • Calcium(Every 2 months for the first 6 months, then every 6 months for two years)
  • Potassium(Every 2 months for the first 6 months, then every 6 months for two years)
  • Phosphorus(Every 2 months for the first 6 months, then every 6 months for two years)
  • Indirect bilirubin(Every 2 months for the first 6 months, then every 6 months for two years)
  • Aspartate Amino Transferase(Every 2 months for the first 6 months, then every 6 months for two years)
  • Thyroid stimulating hormone(Every 2 months for the first 6 months, then every 6 months for two years)
  • Lactic acid(Every 2 months for the first 6 months, then every 6 months for two years)
  • Fasting Blood Glucose(Every 2 months for the first 6 months, then every 6 months for two years)
  • Insulin(Every 2 months for the first 6 months, then every 6 months for two years)
  • Urea(Every 2 months for the first 6 months, then every 6 months for two years)
  • Albumin(Every 2 months for the first 6 months, then every 6 months for two years)
  • Direct bilirubin(Every 2 months for the first 6 months, then every 6 months for two years)
  • High Density Lipoproteins(Every 2 months for the first 6 months, then every 6 months for two years)
  • HCO3 (Bicarbonate ion plasma concentration)(Every 2 months for the first 6 months, then every 6 months for two years)
  • Arterial pH(Every 2 months for the first 6 months, then every 6 months for two years)
  • Hemoglobin(Every 2 months for the first 6 months, then every 6 months for two years)
  • Uric acid(Every 2 months for the first 6 months, then every 6 months for two years)
  • Magnesium(Every 2 months for the first 6 months, then every 6 months for two years)
  • Total bilirubin(Every 2 months for the first 6 months, then every 6 months for two years)
  • Total cholesterol(Every 2 months for the first 6 months, then every 6 months for two years)
  • Gasometric variables, Partial pressure of oxygen (PaO2)(Every 2 months for the first 6 months, then every 6 months for two years)
  • Alanine aminotransferase(Every 2 months for the first 6 months, then every 6 months for two years)
  • Creatinine(Every 2 months for the first 6 months, then every 6 months for two years)
  • Sodium(Every 2 months for the first 6 months, then every 6 months for two years)
  • Protein C Reactive(Every 2 months for the first 6 months, then every 6 months for two years)
  • Triiodothyronine(Every 2 months for the first 6 months, then every 6 months for two years)
  • Triglycerides(Every 2 months for the first 6 months, then every 6 months for two years)
  • Low Density lipoproteins(Every 2 months for the first 6 months, then every 6 months for two years)
  • Thyroxine(Every 2 months for the first 6 months, then every 6 months for two years)
  • Cholecalciferol(Every 2 months for the first 6 months, then every 6 months for two years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco J. Nachón García

MD. PhD Senior Researcher of the Institute of Health Sciences at Universidad Veracruzana Xalapa

Universidad Veracruzana

研究点 (2)

Loading locations...

相似试验

Very Low Calorie Ketogenic Low-fat Diet (VLCKLFD) | 临床试验